Skip to content

clinical research industry

Running a Site 3 Minute Read

Never miss another re-consent: The benefits of an integrated eConsent-eSource solution

With the recent push toward Decentralized Clinical Trials (DCTs), many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs, investigators and patients these benefits: Reduce errors by ensuring completion of all fields Automated audit trails ensure accuracy of date-times...

Running a Study
2 Minute Read -

Ask Me Anything – Hitting the Target with Good Study Design

Mary Brenner, MSN MArch RN, is CRIO’s Study Design Manager and brings deep-rooted expertise as a registered nurse to CRIO’s in-house study design team. In this quick Q&A, Mary shares the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and gives tips for designing it on your...

CRIO Company News
2 Minute Read -

CRIO continues record growth in 2022, more than doubling the number of clinical research sites supporting over 800 life science sponsors

BOSTON, MA – August 9, 2022 – CRIO, a Boston-based healthcare technology company streamlining clinical trials for sponsors, sites and patients, announced that it has reached another milestone, exceeding 2,000 clinical research sites standardizing on CRIO’s eSource platform. CRIO supports a variety of clinical trial data. To date, over 800 life science sponsors have data...

CRIO Company News
1 Minute Read -

Clinical Research IO (CRIO) Ranked Among Best Clinical Trial Management Software Companies of 2021

CRIO has been highlighted among the top solutions that help researchers track application deadlines, project milestones, and participant demographics. BOSTON, MA –  August 24, 2021 – Clinical Research IO (CRIO), a Boston-based company working to transform the clinical research industry with the latest in the cloud and SaaS technology, has been named among the best...

Running a Site 4 Minute Read

Leadership & technology – Preparing your site for the future of clinical trials

Leadership’s role in empowering emotional resilience and adaptation in the clinical research industry. For the last 25 years, the founders of BioNTech have been dedicated to using mRNA technology in the treatment of cancer. In January 2020, the company’s leadership identified that their innovative technology could be applied to a COVID-19 vaccine – and the...

Running a Site
3 Minute Read -

Technology Innovation in Clinical Trials is Here to Stay

The staying power of technology after the pandemic  The clinical trials industry has historically been slow to adopt innovation, but 2020 was a catalyst for transformation. Spurred on by the need for business continuity during the pandemic, sites and sponsors worldwide were highly motivated to reconsider business as usual, and many have adopted an array...

Running a Study
7 Minute Read -

A Look into Alzheimer’s Research with Dr. Craig Curtis

How did you get into clinical research? During medical school, I completed several research externships and became very interested in research, but did not think of it as a career. After graduating and moving to Florida for residency, I met a local physician who was a principal investigator and owned a clinical research site.  We...

Running a Study
2 Minute Read -

Cytel’s COVID Trial Tracker indicates that the number of COVID clinical trials is still rapidly increasing

Since Clinical Research IO first visited Cytel’s COVID trial tracker in April 2020, the number of treatment and vaccine trials has almost tripled. To date, there are 1,751 COVID studies. Given that the speed of protocol design and study start up has drastically increased throughout the pandemic, we can expect this number to continue rising....

Running a Site
4 Minute Read -

Industry experts counsel on staffing models, patient recruitment and remote monitoring in the new normal

According to the latest survey by Clinical Research IO, clinical trials have largely re-opened. While we should remain optimistic about the restart, Dr. Lindsay McNair, Chief Medical Officer of WCG, reminds us that “we are not post-COVID in many ways.” Given that clinical trials will have to take place amid the ongoing pandemic, “we should...

Get articles delivered to your inbox, every week